INACTIVATED IBD+ ND
Infectious Bursal Disease & Newcastle Disease Vaccine, Inactivated, Standard Type 1 & Variant-Delaware A and E & Maryland strain & LaSota strains
For Breeder Hens
This vaccine has been developed for use in breeder hens to give broad protection against Newcastle Disease and Infectious Bursal disease (Gumboro disease). When injected, the vaccine produces a high level of circulating antibody (humoral immunity), which is maintained throughout the production cycle. This provides high levels of parental immunity in the progeny. This is the only way to provide protection to the chicks during the critical first few days of life. Early infection with IBD (Gumboro disease) causes permanent damage to the immune system (immunosuppression) and leaves the flock susceptible to many other diseases.
Is produced with high tittering strains of Infectious Bursal disease (IBD) and Newcastle disease viruses, suspended in a stable oil emulsion. By concentrating the virus antigens, large amounts of antigens are provided in a 1/2 ml dose. When injected, the oil emulsion controls the absorption of the virus and greatly enhances the development of high levels of immunity. The product meets rigid 'Quality Control' standards of Purity, Safety and Potency as per individual monographs of viral vaccines
Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 Newcastle disease virus and 1 x
106.2 TCID50 Infectious Bursal disease virus.
It is completely safe because it contains no living virus. It can safely be administered at any age. It cannot spread from vaccinated to susceptible flocks. It provides high and persistent levels of antibody in the dams to provide parental immunity to the progeny. Newcastle disease and IBD immunity are delivered to the farm with the chicks.
Dosage & Administration
Warning: Do not vaccinate within 42 days before slaughter.
Birds should be "primed" with live virus vaccines for Bursal disease and Newcastle Disease at least 4 weeks prior to the use of this vaccine. Vaccinate with this vaccine between 16 and 20 weeks of age. If birds are held for a second year, revaccinate during molt. Dosage is 1/2 ml (0.5 ml) per bird. Vaccine should be brought to room temperature before use. Inject subcutaneously in the lower neck region using aseptic technique. Inject all birds in the flock.
The capability of this vaccine to produce satisfactory results depends upon many factors, including - but not limited to - conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual chickens, and degree of field exposure. Therefore, directions for use should be followed carefully.
- Do not use chemical disinfectants for sterilization
- Remove the vaccine from refrigerator at least 1 day before vaccination for better results
- Use entire contents
- Shake well before and during use
- Vaccinate only healthy birds
- Use entire contents of bottle when first opened
- For veterinary use only
Packaging & Storage
This vaccine is available in 500 ml polypropylene bottles. Each contains 500 and 1000 doses of vaccine, packed 18 bottles per case.
Store between 2°C and 8°C. Do not freeze. Protect from light.